During the initial CAR T-cell therapy period, the total cost of care ranged from $350,000 to more than $2 million

Oral selective estrogen receptor degraders Agent Status and key trial data What to watch Elacestrant (Orserdu) Approved in 2023 as the first oral SERD in ESR1-mutant metastatic breast cancer via...

Notice of privacy practices Effective Date: January 2026 THIS NOTICE DESCRIBES HOW MEDICAL INFORMATION ABOUT YOU MAY BE USED AND DISCLOSED AND HOW YOU CAN GET ACCESS TO THIS INFORMATION. PLEASE...

Education information Biometric information Legally protected classification characteristics We collect this information directly from you when you provide it by applying for a job, accepting a job...

Fall 2024 edition provides insights into groundbreaking specialty solutions for managed care

Cover image for The state of value-based contracting 2.0 An update on Medicaid payment models and opportunities Prime Therapeutics Value-based contracts (VBCs) are performance-based reimbursement...

Abby Kim, PharmD, BCOP, shares how artificial intelligence and novel screening tools are helping to prevent and detect cancer better and sooner

cover image for Drug Approvals: December 2024 Critical updates in an ever-changing environment Prime Therapeutics /drug-approvals-december-2024 About Prime Therapeutics Prime Therapeutics logo...